Clinical trials: BOS

Eosinophilic Esophagitis (EoE)

Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)

• Terminated
• Age: 11 to 55 years
• Phase 3
• Pill or oral medicine
• Results posted

This is a continuation study of Budesonide Oral Suspension (BOS) in adults and adolescents with Eosinophilic Esophagitis (EoE) who have completed participation in the SHP621-302 extension study.

Trial name

NCT03245840

Testing

Budesonide oral suspension

Where

45 sites in United States

Volunteers

133 people

Sponsor

Shire